Authorities say Cephalon marketed one of the drugs, Actiq, for maladies including migraines and injuries. But authorities say the fentanyl lollipop is a highly addictive narcotic only approved for certain cancer patients.
The suburban Philadelphia company has signed an agreement to plead guilty to one count of distribution of misbranded drugs.
